Double blind cross-over study of the inotropic influence of Tiprenolol (DU21445) and propranolol in patients with ischaemic heart disease.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001916:Brachial Artery; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D003327:Coronary Disease / Q000503:physiopathology*; D003864:Depression, Chemical; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D005082:Physical Exertion; D010919:Placebos; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology; D011651:Pulmonary Artery; D013440:Sulfides / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011412:Propanolamines; D011437:Propylamines; D013440:Sulfides; D011433:Propranolol